The Concentrations of Interleukin-6, Insulin, and Glucagon in the Context of Obesity and Type 2 Diabetes and Single Nucleotide Polymorphisms in IL6 and INS Genes

Obesity and diabetes are a problem of modern medicine. Although the environmental factors contributing to the development of these diseases are widely known, research into genetic factors is still ongoing. At the same time, the role of inflammation in the pathophysiology of obesity and diabetes is i...

Full description

Saved in:
Bibliographic Details
Main Authors: Magdalena Król-Kulikowska, Iwona Urbanowicz, Marta Kepinska
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Journal of Obesity
Online Access:http://dx.doi.org/10.1155/2024/7529779
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849387220050378752
author Magdalena Król-Kulikowska
Iwona Urbanowicz
Marta Kepinska
author_facet Magdalena Król-Kulikowska
Iwona Urbanowicz
Marta Kepinska
author_sort Magdalena Król-Kulikowska
collection DOAJ
description Obesity and diabetes are a problem of modern medicine. Although the environmental factors contributing to the development of these diseases are widely known, research into genetic factors is still ongoing. At the same time, the role of inflammation in the pathophysiology of obesity and diabetes is increasingly emphasized. Therefore, the purpose of this study was to investigate the influence of two selected polymorphisms (rs1800795 and rs3842729) on the development of obesity and type 2 diabetes. In this study, 118 participants were examined, including a control group (nonobese and nondiabetic group), an obese group, and a diabetic group. Genotype analysis was performed using the PCR-RFLP method. It has been shown that in patients with the G/G genotype within the rs1800795 polymorphism (IL6), the chance of developing type 2 diabetes is several times lower compared to patients with the G/C and C/C genotypes. However, the rs3842729 polymorphism (INS) does not directly affect the risk of obesity or type 2 diabetes (T2D), although elevated insulin concentrations have been observed in obese and diabetic patients. These results confirm the impact of the rs1800795 polymorphism on the development of diabetes; however, this relationship is more complex and requires further research on other factors.
format Article
id doaj-art-2c4384697e734df38fcd98aea36172d0
institution Kabale University
issn 2090-0716
language English
publishDate 2024-01-01
publisher Wiley
record_format Article
series Journal of Obesity
spelling doaj-art-2c4384697e734df38fcd98aea36172d02025-08-20T03:55:17ZengWileyJournal of Obesity2090-07162024-01-01202410.1155/2024/7529779The Concentrations of Interleukin-6, Insulin, and Glucagon in the Context of Obesity and Type 2 Diabetes and Single Nucleotide Polymorphisms in IL6 and INS GenesMagdalena Król-Kulikowska0Iwona Urbanowicz1Marta Kepinska2Department of Pharmaceutical BiochemistryDepartment of Clinical Chemistry and Laboratory HematologyDepartment of Pharmaceutical BiochemistryObesity and diabetes are a problem of modern medicine. Although the environmental factors contributing to the development of these diseases are widely known, research into genetic factors is still ongoing. At the same time, the role of inflammation in the pathophysiology of obesity and diabetes is increasingly emphasized. Therefore, the purpose of this study was to investigate the influence of two selected polymorphisms (rs1800795 and rs3842729) on the development of obesity and type 2 diabetes. In this study, 118 participants were examined, including a control group (nonobese and nondiabetic group), an obese group, and a diabetic group. Genotype analysis was performed using the PCR-RFLP method. It has been shown that in patients with the G/G genotype within the rs1800795 polymorphism (IL6), the chance of developing type 2 diabetes is several times lower compared to patients with the G/C and C/C genotypes. However, the rs3842729 polymorphism (INS) does not directly affect the risk of obesity or type 2 diabetes (T2D), although elevated insulin concentrations have been observed in obese and diabetic patients. These results confirm the impact of the rs1800795 polymorphism on the development of diabetes; however, this relationship is more complex and requires further research on other factors.http://dx.doi.org/10.1155/2024/7529779
spellingShingle Magdalena Król-Kulikowska
Iwona Urbanowicz
Marta Kepinska
The Concentrations of Interleukin-6, Insulin, and Glucagon in the Context of Obesity and Type 2 Diabetes and Single Nucleotide Polymorphisms in IL6 and INS Genes
Journal of Obesity
title The Concentrations of Interleukin-6, Insulin, and Glucagon in the Context of Obesity and Type 2 Diabetes and Single Nucleotide Polymorphisms in IL6 and INS Genes
title_full The Concentrations of Interleukin-6, Insulin, and Glucagon in the Context of Obesity and Type 2 Diabetes and Single Nucleotide Polymorphisms in IL6 and INS Genes
title_fullStr The Concentrations of Interleukin-6, Insulin, and Glucagon in the Context of Obesity and Type 2 Diabetes and Single Nucleotide Polymorphisms in IL6 and INS Genes
title_full_unstemmed The Concentrations of Interleukin-6, Insulin, and Glucagon in the Context of Obesity and Type 2 Diabetes and Single Nucleotide Polymorphisms in IL6 and INS Genes
title_short The Concentrations of Interleukin-6, Insulin, and Glucagon in the Context of Obesity and Type 2 Diabetes and Single Nucleotide Polymorphisms in IL6 and INS Genes
title_sort concentrations of interleukin 6 insulin and glucagon in the context of obesity and type 2 diabetes and single nucleotide polymorphisms in il6 and ins genes
url http://dx.doi.org/10.1155/2024/7529779
work_keys_str_mv AT magdalenakrolkulikowska theconcentrationsofinterleukin6insulinandglucagoninthecontextofobesityandtype2diabetesandsinglenucleotidepolymorphismsinil6andinsgenes
AT iwonaurbanowicz theconcentrationsofinterleukin6insulinandglucagoninthecontextofobesityandtype2diabetesandsinglenucleotidepolymorphismsinil6andinsgenes
AT martakepinska theconcentrationsofinterleukin6insulinandglucagoninthecontextofobesityandtype2diabetesandsinglenucleotidepolymorphismsinil6andinsgenes
AT magdalenakrolkulikowska concentrationsofinterleukin6insulinandglucagoninthecontextofobesityandtype2diabetesandsinglenucleotidepolymorphismsinil6andinsgenes
AT iwonaurbanowicz concentrationsofinterleukin6insulinandglucagoninthecontextofobesityandtype2diabetesandsinglenucleotidepolymorphismsinil6andinsgenes
AT martakepinska concentrationsofinterleukin6insulinandglucagoninthecontextofobesityandtype2diabetesandsinglenucleotidepolymorphismsinil6andinsgenes